Kto publikuje wyniki i kiedy, na najbliższe tygodnie. Kalendarz pochodzi ze źródła zewnętrznego; każdą liczbę obok — ocenę, wielkość, wskaźnik — liczymy z własnych raportów spółki złożonych do SEC.
W tym miesiącu zaplanowane 2363 spółki, z czego 2330 pokrywamy.
| Spółka | Ocena | Wielkość | C/Z | Dane |
|---|---|---|---|---|
| PFE | B | 163,8B USD | 37,80 | — |
| MPC | B | 110,1B USD | 13,50 | — |
| RACE | B | 71,7B USD | 39,51 | — |
| APO | C | 70,3B USD | 43,59 | — |
| MPLX | C | 57,8B USD | — | — |
| TEVA | A | 46,3B USD | 66,29 | — |
A | 43,3B USD | 28,90 | — | |
D | 26,9B USD | 22,13 | — | |
D | 24,8B USD | — | — | |
D | 24,4B USD | 27,37 | — | |
D | 23,8B USD | 23,45 | — | |
A | 17,8B USD | 34,38 | — | |
D | 3,2B USD | — | — | |
A | 1,7B USD | — | — | |
F | 1,1B USD | — | — | |
| LBTYBnie pokrywamy | Bez oceny | — | — | — |
| LBTYKnie pokrywamy | Bez oceny | — | — | — |
| Spółka | Ocena | Wielkość | C/Z | Dane |
|---|---|---|---|---|
A | 14,1B USD | 16,62 | — | |
A | 2,6B USD | 17,32 | — | |
B | 1,8B USD | — | — | |
C | 1,1B USD | 8,51 | — | |
A | 637,4M USD | — | — |
| Spółka | Ocena | Wielkość | C/Z | Dane |
|---|---|---|---|---|
A | 992B USD | 156,21 | — | |
| Bez oceny | 728,3B USD | — | — | |
A | 255,8B USD | 63,98 | — | |
A | 229B USD | 26,31 | — | |
A | 193,1B USD | 100,18 | — | |
A |
| 168,3B USD |
| 44,08 |
| — |
A | 141,7B USD | 15,18 | — |
A | 94,3B USD | 37,40 | — |
A | 87,3B USD | — | — |
C | 80,6B USD | 19,74 | — |
F | 76,2B USD | — | — |
B | 62,1B USD | 177,13 | — |
A | 57B USD | 12,22 | — |
B | 51,9B USD | 51,21 | — |
B | 43,6B USD | 110,55 | — |
B | 41,6B USD | — | — |
B | 40,3B USD | — | — |
| ITUB | A | 40,1B USD | — | — |
| AIG | C | 39,4B USD | 13,76 | — |
| ADM | D | 38,3B USD | 21,76 | — |
| YUM | A | 37,6B USD | 17,33 | — |
| AXON | A | 34,1B USD | 174,02 | — |
| KGC | A | 29,2B USD | 12,48 | — |
| MLM | B | 28,8B USD | 11,77 | — |
| SMCI | D | 27B USD | 12,62 | — |
| CPNG | C | 25,1B USD | — | — |
| ES | A | 24,1B USD | 16,56 | — |
| GPN | C | 22,1B USD | — | — |
| IFF | C | 21,7B USD | 74,77 | — |
| RIVN | C | 19,3B USD | — | — |
| BR | A | 18,4B USD | 16,77 | — |
| TOST | B | 18,2B USD | 38,56 | — |
| WES | B | 17,7B USD | — | — |
| CDW | C | 16,2B USD | 15,60 | — |
| OVV | B | 16,2B USD | 16,86 | — |
| LDOS | A | 15,5B USD | 11,50 | — |
| BALL | A | 15B USD | 16,09 | — |
| TEM | D | 14,8B USD | — | — |
| EXEL | A | 14,5B USD | 18,45 | — |
| EQH | F | 14,2B USD | — | — |
| YUMC | B | 14B USD | 14,94 | — |
| EMBJ | B | 13,9B USD | 40,07 | — |
| ULS | A | 13,2B USD | 26,16 | — |
| GRAB | C | 13,2B USD | 52,17 | — |
| AIZ | A | 13B USD | 12,61 | — |
| CORT | C | 12,4B USD | 273,31 | — |
| MDGL | C | 11,8B USD | — | — |
| IT | B | 11,7B USD | 16,75 | — |
| AFG | A | 11,5B USD | 12,10 | — |
| HUT | D | 11,4B USD | — | — |
| AEIS | C | 11,3B USD | 52,64 | — |
| WTRG | D | 11,1B USD | 20,02 | — |
| PINS | A | 11,1B USD | 54,51 | — |
| IAG | A | 11B USD | 16,34 | — |
| PSKY | C | 10,7B USD | — | — |
| AES | C | 10,6B USD | 5,67 | — |
| JKHY | A | 10,3B USD | 20,98 | — |
| QGEN | C | 9,6B USD | 22,88 | — |
| HSIC | B | 9,5B USD | 24,78 | — |
| IBRX | B | 9,4B USD | — | — |
| MTCH | A | 9,2B USD | 14,18 | — |
| KYMR | D | 9,2B USD | — | — |
| LTH | C | 9B USD | 21,79 | — |
| JXN | C | 8,9B USD | 154,60 | — |
| VOYA | D | 8,6B USD | 16,03 | — |
| PCVX | Bez oceny | 8,4B USD | — | — |
| JAN | A | 8,1B USD | — | — |
| HNGE | A | 7,8B USD | 31,53 | — |
| CBC | Bez oceny | 7,6B USD | 18,09 | — |
| PCTY | A | 7,5B USD | 28,77 | — |
| SYRE | F | 7,5B USD | — | — |
| SLAB | F | 7,4B USD | — | — |
| CHRD | C | 7,4B USD | 9,02 | — |
| MOS | F | 7,1B USD | — | — |
| ZETA | A | 7B USD | — | — |
| SSRM | A | 6,9B USD | 30,58 | — |
| COMP | B | 6,8B USD | 150,17 | — |
| NCLH | D | 6,8B USD | 9,14 | — |
| MATX | B | 6,8B USD | 15,21 | — |
| AUGO | A | 6,7B USD | — | — |
| RYTM | C | 6,6B USD | — | — |
| NPO | A | 6,5B USD | 148,53 | — |
| MAC | F | 6,5B USD | — | — |
| TFPM | A | 6,4B USD | 20,57 | — |
| FMS | C | 6,2B USD | 5,91 | — |
| CAVA | B | 6,2B USD | 98,44 | — |
| QLYS | A | 6,2B USD | 30,87 | — |
| INGR | D | 6,1B USD | 10,52 | — |
| CRUS | B | 6,1B USD | 14,75 | — |
| ECG | A | 6B USD | 23,71 | — |
| MIRM | D | 5,7B USD | — | — |
| ADT | A | 5,6B USD | — | — |
| MCY | A | 5,5B USD | 5,90 | — |
| PTCT | D | 5,4B USD | — | — |
| SHC | B | 5,3B USD | 32,63 | — |
| KGS | B | 5,2B USD | 61,67 | — |
| GXO | A | 5,1B USD | 39,62 | — |
| XMTR | B | 5,1B USD | — | — |
| MRCY | B | 5B USD | — | — |
| SPHR | A | 4,8B USD | — | — |
| SKY | C | 4,7B USD | 25,29 | — |
| MARA | F | 4,6B USD | — | — |
| CIGI | B | 4,6B USD | 44,61 | — |
| DAVE | A | 4,6B USD | 21,19 | — |
| CRC | C | 4,5B USD | — | — |
| TREX | A | 4,5B USD | 26,07 | — |
| RDN | A | 4,3B USD | 8,42 | — |
| PAM | D | 4,2B USD | 6,67 | — |
| TNGX | F | 4,1B USD | — | — |
| ACLS | D | 4B USD | 43,16 | — |
| PARR | B | 3,9B USD | 4,57 | — |
| ERO | A | 3,9B USD | 14,69 | — |
| CRVL | A | 3,8B USD | 33,12 | — |
| SUNC | A | 3,8B USD | — | — |
| VCYT | A | 3,7B USD | 32,91 | — |
| IDYA | D | 3,6B USD | — | — |
| TARS | A | 3,4B USD | — | — |
| IPGP | C | 3,3B USD | 120,70 | — |
| CDNA | B | 3,3B USD | 30,93 | — |
| VGNT | Bez oceny | 3,2B USD | — | — |
| ASH | B | 3,1B USD | 65,19 | — |
| ATRO | A | 3,1B USD | 35,66 | — |
| NMIH | A | 3,1B USD | 8,01 | — |
| BHE | B | 3B USD | 57,21 | — |
| KNF | B | 3B USD | 21,51 | — |
| BWIN | A | 3B USD | — | — |
| OUST | C | 2,9B USD | — | — |
| GPK | C | 2,7B USD | 13,95 | — |
| MZTI | A | 2,7B USD | 14,31 | — |
| INTA | A | 2,7B USD | — | — |
| GPOR | B | 2,7B USD | 6,07 | — |
| TDC | B | 2,7B USD | 6,03 | — |
| HOG | F | 2,6B USD | 13,63 | — |
| SUPN | C | 2,6B USD | — | — |
| BEAM | C | 2,5B USD | — | — |
| KD | D | 2,5B USD | 30,51 | — |
| IOSP | D | 2,4B USD | 19,74 | — |
| CLOV | A | 2,3B USD | — | — |
| LTC | A | 2,3B USD | 15,46 | — |
| HRMY | A | 2,3B USD | 12,71 | — |
| UPST | D | 2,3B USD | 47,22 | — |
| ANDE | D | 2,3B USD | 30,95 | — |
| FLYW | A | 2,2B USD | 66,65 | — |
| HG | A | 2,2B USD | 5,84 | — |
| AUPH | A | 2,2B USD | 7,17 | — |
| ALGT | A | 2,1B USD | 52,81 | — |
| UNIT | D | 2,1B USD | 5,50 | — |
| LIND | A | 2,1B USD | — | — |
| DRVN | B | 1,9B USD | 11,81 | — |
| PRDO | A | 1,9B USD | 10,95 | — |
| ATEN | B | 1,9B USD | 43,76 | — |
| BRSL | F | 1,9B USD | 10,05 | — |
| NGL | D | 1,9B USD | — | — |
| LIME | Bez oceny | 1,8B USD | — | — |
| HMN | A | 1,8B USD | 10,64 | — |
| WMK | B | 1,8B USD | 18,18 | — |
| CMRE | B | 1,8B USD | — | — |
| CMPS | Bez oceny | 1,8B USD | — | — |
| TSLX | Bez oceny | 1,7B USD | 19,52 | — |
| PSNL | D | 1,7B USD | — | — |
| OCUL | F | 1,7B USD | — | — |
| STOK | F | 1,7B USD | — | — |
| CPRI | D | 1,7B USD | 11,28 | — |
| TSHA | F | 1,6B USD | — | — |
| DEI | D | 1,6B USD | — | — |
| GENI | B | 1,6B USD | — | — |
| PAX | A | 1,5B USD | 21,54 | — |
| RVLV | C | 1,5B USD | 21,06 | — |
| RARE | C | 1,5B USD | — | — |
| ANAB | B | 1,5B USD | 8,77 | — |
| NVGS | B | 1,5B USD | 10,64 | — |
| CRSR | B | 1,5B USD | 43,42 | — |
| NRP | F | 1,5B USD | — | — |
| MBC | D | 1,4B USD | — | — |
| APPS | C | 1,4B USD | — | — |
| HLMN | B | 1,4B USD | 32,36 | — |
| UFCS | A | 1,4B USD | 9,95 | — |
| CRCT | B | 1,4B USD | 15,25 | — |
| SHLS | D | 1,3B USD | 40,95 | — |
| AGL | C | 1,3B USD | — | — |
| INNV | A | 1,2B USD | — | — |
| VTOL | C | 1,2B USD | 11,82 | — |
| AIP | A | 1,1B USD | — | — |
| SQNS | F | 1,1B USD | 3,50 | — |
| HGTY | B | 1,1B USD | — | — |
| GDRX | B | 1,1B USD | 80,75 | — |
| BOW | A | 1,1B USD | 18,26 | — |
| LGIH | B | 1,1B USD | 16,79 | — |
| CDRE | A | 1,1B USD | 31,43 | — |
| GO | C | 1,1B USD | — | — |
| WLFC | B | 1,1B USD | 5,45 | — |
| ECVT | B | 1,1B USD | — | — |
| PRCT | C | 1B USD | — | — |
| FTK | A | 1B USD | 29,36 | — |
| CWEN | A | 1B USD | 39,04 | — |
| ZEPP | D | 1B USD | — | — |
| CRVS | Bez oceny | 986,7M USD | — | — |
| BVS | A | 986,7M USD | 18,19 | — |
| XIFR | D | 983,3M USD | — | — |
| KURA | D | 960,8M USD | — | — |
| CBLL | D | 954,1M USD | — | — |
| RIGL | B | 913,1M USD | 2,90 | — |
| ACEL | A | 883,4M USD | 16,24 | — |
| VPG | F | 878,6M USD | 238,97 | — |
| CYRX | C | 876,7M USD | — | — |
| BW | C | 867M USD | — | — |
| OI | F | 866,6M USD | — | — |
| MNTN | A | 815,7M USD | 9,41 | — |
| SXC | D | 791M USD | — | — |
| RPD | C | 788,9M USD | 37,76 | — |
| TXO | F | 781,8M USD | — | — |
| AHCO | C | 774,4M USD | — | — |
| CGBD | Bez oceny | 763,4M USD | 22,19 | — |
| LUCK | D | 747,4M USD | — | — |
| EVC | A | 731,4M USD | 734,00 | — |
| SWIM | B | 722,3M USD | 122,80 | — |
| VSTM | D | 716,4M USD | — | — |
| PSTL | A | 704,2M USD | 43,11 | — |
| OABI | D | 689,2M USD | — | — |
| MG | A | 680,6M USD | 25,75 | — |
| EVEX | Bez oceny | 679,5M USD | — | — |
| TSAT | F | 671,1M USD | — | — |
| NVCT | Bez oceny | 669,9M USD | — | — |
| FWRG | C | 640,9M USD | 35,81 | — |
| SLRC | Bez oceny | 638,8M USD | 8,67 | — |
| GAIN | Bez oceny | 630M USD | 65,34 | — |
| RSVR | B | 625,7M USD | 79,08 | — |
| BXC | C | 588,1M USD | — | — |
| DDD | C | 583,2M USD | — | — |
| NCDL | Bez oceny | 576,3M USD | 6,27 | — |
| LMB | A | 571,5M USD | 19,17 | — |
| HY | F | 571M USD | — | — |
| SOPH | B | 567,8M USD | — | — |
| DCTH | B | 549,6M USD | 1584,00 | — |
| RYAM | F | 542,5M USD | — | — |
| HTZ | D | 533,6M USD | — | — |
| SLDP | D | 519,1M USD | — | — |
| ONT | C | 495,2M USD | — | — |
| NPCE | D | 479,5M USD | — | — |
| XRN | A | 470,3M USD | 9,12 | — |
| WEYS | B | 464,1M USD | 13,39 | — |
| BXDC | Bez oceny | 445M USD | — | — |
| MEC | C | 416,8M USD | — | — |
| VITL | D | 402,3M USD | — | — |
| TRVG | D | 398M USD | 32,67 | — |
| OFIX | C | 397,3M USD | — | — |
| OPRT | D | 378,9M USD | 20,60 | — |
| SNDL | A | 360,8M USD | — | — |
| CLNE | C | 348,3M USD | — | — |
| LVWR | C | 334,8M USD | — | — |
| OEC | D | 328,4M USD | — | — |
| EGHT | B | 312M USD | 54,00 | — |
| EPRX | F | 295,8M USD | — | — |
| FOA | D | 293,8M USD | — | — |
| AUDC | B | 286,3M USD | 34,10 | — |
| PMTS | A | 286M USD | 21,75 | — |
| LAB | F | 280,3M USD | 3,25 | — |
| REFI | D | 273,6M USD | 7,80 | — |
| ACIU | F | 263,5M USD | — | — |
| PTLO | C | 260,4M USD | 19,78 | — |
| INFU | C | 259,1M USD | 32,53 | — |
| AVNW | A | 251,3M USD | 103,32 | — |
| HCKT | F | 245,3M USD | 15,17 | — |
| NAGE | B | 234,6M USD | 16,47 | — |
| ANGI | D | 231M USD | — | — |
| MBI | C | 219,4M USD | — | — |
| AMWL | D | 219,4M USD | — | — |
| AHT | D | 209M USD | — | — |
| NSLR | Bez oceny | 205,3M USD | 1,97 | — |
| XGN | B | 201,2M USD | — | — |
| CMT | F | 200,1M USD | 26,29 | — |
| CXDO | A | 194,9M USD | 41,86 | — |
| MITT | D | 190,2M USD | 7,97 | — |
| STIM | B | 178,3M USD | — | — |
| EML | D | 140M USD | 19,88 | — |
| DOUG | D | 137,2M USD | 5,21 | — |
| OXSQ | Bez oceny | 136,8M USD | — | — |
| ACNT | F | 129,3M USD | — | — |
| UFI | C | 124,3M USD | — | — |
| BOOM | F | 116,1M USD | — | — |
| CPIX | F | 115M USD | — | — |
| BMEA | Bez oceny | 91,7M USD | — | — |
| AEYE | A | 83,5M USD | — | — |
| LFVN | D | 78,9M USD | 15,75 | — |
| GECC | Bez oceny | 72,7M USD | — | — |
| SCOR | F | 71,7M USD | — | — |
| EVTL | Bez oceny | 64,3M USD | — | — |
| HRTX | C | 58,6M USD | — | — |
| FTEK | F | 51,2M USD | — | — |
| HOWL | Bez oceny | 44M USD | — | — |
| NSPR | D | 32,1M USD | — | — |
| COHN | C | 31M USD | 2,05 | — |
| KTCC | F | 23,2M USD | — | — |
| UONE | F | 18,7M USD | — | — |
| RDNW | D | 13,7M USD | — | — |
| DRK | F | 12,4M USD | — | — |
| PRPL | D | 9,9M USD | — | — |
| SNOA | B | 6,1M USD | — | — |
| XXII | F | 97,3K USD | — | — |
| TAP | C | 0,00 USD | — | — |
| HLNE | B | — | — | — |
| IQMX | Bez oceny | — | — | — |
| PJT | A | — | — | — |
| TAP.Anie pokrywamy | Bez oceny | — | — | — |
| UONEKnie pokrywamy | Bez oceny | — | — | — |
| WTTR | F | — | — | — |